Aug. 07, 2025 —- New research by European cybersecurity company Modat revealed more than 1.2 million internet-connected healthcare devices and systems are exposed and vulnerable to exploitation ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
-
-
The American Heart Association recently announced that Dr. Christine E. Seidman, an internationally renowned physician-scientist and pioneer in cardiovascular genetics, has been selected as the ...
-
April 9, 2024 — The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with evidence of improvements in symptoms and exercise capacity among people with ...
-
April 9, 2024 — Using a web application to qualify individuals for treatment with a nonprescription statin closely matched the results of clinician assessments in determining a person’s eligibility ...
Nov. 19, 2025 — Promising results from a pivotal Phase 3 clinical trial of an investigational heart-attack drug were ...
November 19, 2025
Sept. 25, 2025 — Kardigan has introduced the three late-stage clinical programs leading its robust pipeline, each ...
September 25, 2025
Sept. 23, 2025 — CeleCor Therapeutics’ multinational Phase 3 clinical trial of its investigational heart-attack drug ...
September 23, 2025
Sept. 2, 2025 —Corsera Health, Inc. has announced its launch with a mission to extend healthspan through cardiovascular ...
September 05, 2025
Aug. 07, 2025 —- New research by European cybersecurity company Modat revealed more than 1.2 million internet-connected ...
August 08, 2025
July 25, 2025 — Data in recent staffing surveys from the American Society of Radiologic Technologists show that vacancy ...
July 25, 2025
The American Heart Association recently announced that Dr. Christine E. Seidman, an internationally renowned physician ...
May 02, 2025
July 10, 2024 — Reviva Pharmaceuticals Holdings, Inc., a late-stage pharmaceutical company developing therapies that ...
July 10, 2024
June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...
June 26, 2024
June 21, 2024 — Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of ...
June 21, 2024
June 5, 2024 —  Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced a new post-hoc analysis of clinical data ...
June 05, 2024
May 24, 2024 — Lexicon Pharmaceuticals, Inc. announced a new post-hoc analysis of clinical data showing that INPEFA ...
May 24, 2024
May 22, 2024
May 20, 2024 — Cardiologist Brendan Carry, MD, and a team of Danville, PA-based Geisinger Medical Center physicians have ...
May 20, 2024
May 17, 2024 — The study design and baseline characteristics of FINE-HEART, a new prespecified, exploratory pooled ...
May 17, 2024© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now